Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
SBC Medical Group Holdings Inc
Bear Case (25th pct.)
49.1% vs price
Base Case (Median)
96.2% vs price
Bull Case (75th pct.)
123.0% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $11.67 | 110.0% | High (40%) |
| PE Comparable | $10.91 | 96.2% | Medium (25%) |
| Growth Trajectory DCF | $18.52 | 233.1% | Medium (20%) |
| Graham Number | $5.11 | -8.0% | Medium (40%) |
| EV/EBITDA | $9.36 | 68.4% | Medium (20%) |
| EV/FCF | $13.13 | 136.2% | Medium (20%) |
| Earnings Power Value | $7.22 | 29.8% | Medium (50%) |
Based on 7 out of 7 methods, SBC appears undervalued at the current price of $5.56. The base case fair value of $10.91 implies 96.2% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.